These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31449522)

  • 21. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial.
    Nienhuis WA; Stienstra Y; Thompson WA; Awuah PC; Abass KM; Tuah W; Awua-Boateng NY; Ampadu EO; Siegmund V; Schouten JP; Adjei O; Bretzel G; van der Werf TS
    Lancet; 2010 Feb; 375(9715):664-72. PubMed ID: 20137805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection?
    Ruf MT; Chauty A; Adeye A; Ardant MF; Koussemou H; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1252. PubMed ID: 21829740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
    Sarfo FS; Converse PJ; Almeida DV; Zhang J; Robinson C; Wansbrough-Jones M; Grosset JH
    PLoS Negl Trop Dis; 2013; 7(3):e2101. PubMed ID: 23516649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiology of secondary infections in Buruli ulcer lesions; implications for therapeutic interventions.
    Gyamfi E; Narh CA; Quaye C; Abbass A; Dzudzor B; Mosi L
    BMC Microbiol; 2021 Jan; 21(1):4. PubMed ID: 33402095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection.
    Wanda F; Nkemenang P; Ehounou G; Tchaton M; Comte E; Toutous Trellu L; Masouyé I; Christinet V; O'Brien DP
    BMC Infect Dis; 2014 Jul; 14():423. PubMed ID: 25073531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana.
    Williamson H; Phillips R; Sarfo S; Wansbrough-Jones M; Small P
    PLoS One; 2014; 9(2):e88007. PubMed ID: 24520343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011].
    Bayonne Manou LS; Portaels F; Eddyani M; Book AU; Vandelannoote K; de Jong BC
    Med Sante Trop; 2013; 23(4):450-7. PubMed ID: 24413612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathological changes and clinical responses of Buruli ulcer plaque lesions during chemotherapy: a role for surgical removal of necrotic tissue?
    Ruf MT; Sopoh GE; Brun LV; Dossou AD; Barogui YT; Johnson RC; Pluschke G
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1334. PubMed ID: 21980547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Painful Buruli ulcer in a Malian visitor to France.
    Ezzedine K; Pistone T; Guir V; Malvy D
    Acta Derm Venereol; 2010 Jul; 90(4):424. PubMed ID: 20574617
    [No Abstract]   [Full Text] [Related]  

  • 30. Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial.
    Phillips RO; Robert J; Abass KM; Thompson W; Sarfo FS; Wilson T; Sarpong G; Gateau T; Chauty A; Omollo R; Ochieng Otieno M; Egondi TW; Ampadu EO; Agossadou D; Marion E; Ganlonon L; Wansbrough-Jones M; Grosset J; Macdonald JM; Treadwell T; Saunderson P; Paintsil A; Lehman L; Frimpong M; Sarpong NF; Saizonou R; Tiendrebeogo A; Ohene SA; Stienstra Y; Asiedu KB; van der Werf TS;
    Lancet; 2020 Apr; 395(10232):1259-1267. PubMed ID: 32171422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.
    Addison NO; Pfau S; Koka E; Aboagye SY; Kpeli G; Pluschke G; Yeboah-Manu D; Junghanss T
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005331. PubMed ID: 28245242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay.
    Converse PJ; Almeida DV; Tyagi S; Xu J; Nuermberger EL
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
    Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory confirmation of Buruli ulcer cases in Ghana, 2008-2016.
    Yeboah-Manu D; Aboagye SY; Asare P; Asante-Poku A; Ampah K; Danso E; Owusu-Mireku E; Nakobu Z; Ampadu E
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006560. PubMed ID: 29870529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-oral antibiotic treatment for buruli ulcer: a report of four patients.
    Gordon CL; Buntine JA; Hayman JA; Lavender CJ; Fyfe JA; Hosking P; Starr M; Johnson PD
    PLoS Negl Trop Dis; 2010 Nov; 4(11):e770. PubMed ID: 21152060
    [No Abstract]   [Full Text] [Related]  

  • 37. Combining PCR with microscopy to reduce costs of laboratory diagnosis of Buruli ulcer.
    Yeboah-Manu D; Asante-Poku A; Asan-Ampah K; Ampadu ED; Pluschke G
    Am J Trop Med Hyg; 2011 Nov; 85(5):900-4. PubMed ID: 22049046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buruli ulcer treatment: Rate of surgical intervention differs highly between treatment centers in West Africa.
    Wadagni AC; Steinhorst J; Barogui YT; Catraye PM; Gnimavo R; Abass KM; Amofa G; Frimpong M; Sarpong FN; van der Werf TS; Phillips R; Sopoh GE; Johnson CR; Stienstra Y
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007866. PubMed ID: 31658295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory diagnosis of Buruli ulcer disease.
    Beissner M; Herbinger KH; Bretzel G
    Future Microbiol; 2010 Mar; 5(3):363-70. PubMed ID: 20210548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease.
    Herbinger KH; Adjei O; Awua-Boateng NY; Nienhuis WA; Kunaa L; Siegmund V; Nitschke J; Thompson W; Klutse E; Agbenorku P; Schipf A; Reu S; Racz P; Fleischer B; Beissner M; Fleischmann E; Helfrich K; van der Werf TS; Löscher T; Bretzel G
    Clin Infect Dis; 2009 Apr; 48(8):1055-64. PubMed ID: 19275499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.